This application requests continued Core Support for the University of Pennsylvania Cancer Center's Research Programs and Shared Resources. The University of Pennsylvania Cancer Center is a multidisciplinary interdepartmental institute of the University of Pennsylvania. Its mission is to facilitate cancer research, education, and patient care. While the Center's 273 members are largely drawn from the School of Medicine, representation spans 8 University Schools and 35 Departments. The Cancer Center has three Divisions: Fundamental Research, Clinical Research, and Cancer Control. The Division of Fundamental Research includes programs in Immunobiology, Gene Structure and Regulation, Tumor Cell Biology, and Virology. The Division of Clinical Research includes programs in Clinical Investigations, Melanoma, and Tumor Metabolism; a Pediatric Oncology Research Program was founded in 1992. The Division of Cancer Control, which was established in 1990, houses two programs. These programs were recently renamed Behavioral Sciences Research and Epidemiology and Health Services Research, to reflect their expanded research focus. The recently established Institute for Gene Therapy at Penn has brought critical resources to support a Developing Program in Gene Therapy of Cancer. Ten NCI-funded Shared Resources currently support the needs of Center investigators. The Flow Cytometry and Cell Sorting Facility, Nucleic Acid Facility, Melanoma Core, Biostatistics Unit, and Clinical Research Unit are the oldest. Five new cores are proposed in this application: DNA Sequencing Facility, Confocal Microscopy Core, Computer Modeling Core, Imaging Facility, and Glassware Facility. Interdisciplinary research seminars and research training programs provide valuable opportunities for interdisciplinary interaction and collaboration. Cancer Center developmental funds are used to support faculty recruitment, innovative research, and Shared Resources. Special emphasis will be placed on pilot projects that have the potential for peer-reviewed funding, translational research, innovative clinical trials, and interdisciplinary research initiatives.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016520-20
Application #
2086500
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1978-12-01
Project End
1999-11-30
Budget Start
1995-03-22
Budget End
1995-11-30
Support Year
20
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Huang, Mo; Wang, Jingshu; Torre, Eduardo et al. (2018) SAVER: gene expression recovery for single-cell RNA sequencing. Nat Methods 15:539-542
Yam, Clinton; Xu, Xiaowei; Davies, Michael A et al. (2018) A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors. Clin Cancer Res 24:22-32
Onorati, Angelique V; Dyczynski, Matheus; Ojha, Rani et al. (2018) Targeting autophagy in cancer. Cancer 124:3307-3318
Rebecca, Vito W; Nicastri, Michael C; Fennelly, Colin et al. (2018) PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discov :
Garfall, Alfred L; Stadtmauer, Edward A; Hwang, Wei-Ting et al. (2018) Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI Insight 3:
Jang, Jeong Hoon; Manatunga, Amita K; Taylor, Andrew T et al. (2018) Overall indices for assessing agreement among multiple raters. Stat Med 37:4200-4215
Scheel, John R; Kim, Eunhee; Partridge, Savannah C et al. (2018) MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. AJR Am J Roentgenol 210:1376-1385
Romero, Sally A D; Brown, Justin C; Bauml, Joshua M et al. (2018) Barriers to physical activity: a study of academic and community cancer survivors with pain. J Cancer Surviv 12:744-752
Hinderer, Christian; Katz, Nathan; Buza, Elizabeth L et al. (2018) Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hum Gene Ther 29:285-298
Li, Jinyang; Byrne, Katelyn T; Yan, Fangxue et al. (2018) Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity 49:178-193.e7

Showing the most recent 10 out of 1047 publications